As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...
Researchers at Okayama University in Japan have been studying how Sarunashi juice and tea may protect against the early ...
Ginger Morris can point to any house on the block and tell you who lives there. And whether or not they have cancer. “That ...
A recent study examines the association between COVID-19 infection and an increased risk of recurrence in breast cancer ...
Findings support the ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader, as a potential first-in-class therapy for select advanced or metastatic breast cancers ...
Preclinical data show encouraging activity of azenosertib combinations in ADC-resistant TNBC, supporting the potential for pipeline expansion beyond ovarian cancerReal-world data demonstrate Cyclin E1 ...
Scientists have found the strongest evidence to date that a condition known as Barrett's esophagus is the starting point for ...
A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment
Revolution Medicines announced a stunning survival benefit for its experimental drug in a Phase 3 pancreatic cancer study ...
The Business & Financial Times on MSN
CanCAF launch Cancer Genetic Counselling Certificate Programme
Ghanaian nurse and winner of the 2025 Aster Guardians Global Nursing Award, Naomi Oyoe Ohene Oti, has officially launched the ...
Merck built a wall of patents that keeps a cancer drug's price – and its profits – high. Hospitals often add to the cost for ...
The protein is implicated in a wide swath of cancers, but harnessing it for drug R&D is still a major scientific challenge.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results